Trevena to Present at the 2020 BIO CEO & Investor Conference
05 févr. 2020 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
Trevena to Present at the 2019 Cantor Global Healthcare Conference
27 sept. 2019 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...